Institutional Review Board (IRB)

Our Institutional Review Board (IRB) reviews all human subjects research conducted within the Health Quest System. The mission of the IRB is to protect the rights, privacy, and welfare of all human participants involved in clinical research. To achieve this, the IRB has the authority to review, approve, modify, or disapprove all proposed research study protocols before participants may be enrolled. It is the primary intent of the IRB to ensure that potential subjects are provided with sufficient information to make a free and informed decision about participation in the study.

Related Resources for IRB Members

• VASIRB Member Handbook
• FDA Guidance Sheets

Ethical Codes

• Belmont Report
• Declaration of Helsinki
• Nuremberg Code
• Protection of Human Subjects-21 Code of Federal Regulations Part 50
• Protection of Human Subjects-45 Code of Federal Regulations Part 46

Organizations

• U.S. Department of Health and Human Services (HHS)
• U.S. Food and Drug Administration (FDA)
• Office for Human Research Protections (OHRP)
• National Institutes of Health (NIH)
• National Cancer Institute (NCI)
• Office of Human Subjects Research (OHSR)
• Office of Research Integrity (ORI)
• World Health Organization (WHO)
• International Conference on Harmonization (ICH)
• World Medical Association (WMA)

Websites for Clinical Trials

• ClinicalTrials.gov
• Centerwatch Clinical Trials Network